National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 1994)
1National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 1994)
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 1994).
COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUBSECTION 85 (2AA)
No. PB 5 of 1994
I, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Human Services and Health and Delegate of the Minister for Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:
-
This Declaration shall come into operation on 1 April 1994.
-
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.
THE SCHEDULE
“Banish”
Benzoin
Butyl Monoester Polymer with Ethanol
Butyl Monoester Polymer with Isopropyl Alcohol
“Cancel”
Carmellose Sodium with Pectin and Gelatin
Chloroquine Sulfate
Dimethicone
Ergometrine Maleate with Oxytocin (synthetic)
Isopropyl Monoester Polymer with Isopropyl Alcohol
Octoxinol
“Odorgon”
Oxytocin (synthetic)
Polyisobutylene
Povidone and Vinyl Acetate Copolymer
Sterculia
“Super Banish”
Triamterene
Dated this seventeenth day of March 1994.
D. GRAHAM
Assistant Secretary
Pharmaceutical Benefits Branch
Department of Human Services and Health
Delegate of the Minister for Health